High materiality7/10
Gilead Sciences (GILD) PT Raised to $164 at BofA Securities
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: $164 target vs current price $151.17; implied upside ~9%; bullish.
- Target $164 vs price $151.17; upside ~9%.
Key facts
- 01
Target: $164
- 02
Posted price: $151.17
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.